Thomas Kassberg
2013
In 2013, Thomas Kassberg earned a total compensation of $606.5K as Senior Vice President and Chief Business Officer at Ultragenyx Pharmaceutical, a 64% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $114,345 |
|---|---|
| Option Awards | $182,394 |
| Salary | $289,419 |
| Other | $20,352 |
| Total | $606,510 |
Kassberg received $289.4K in salary, accounting for 48% of the total pay in 2013.
Kassberg also received $114.3K in non-equity incentive plan, $182.4K in option awards and $20.4K in other compensation.
Rankings
In 2013, Thomas Kassberg's compensation ranked 8,679th out of 12,286 executives tracked by ExecPay. In other words, Kassberg earned more than 29.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,679 out of 12,286 | 29th |
Division Manufacturing | 3,153 out of 4,612 | 32nd |
Major group Chemicals And Allied Products | 1,002 out of 1,466 | 32nd |
Industry group Drugs | 762 out of 1,160 | 34th |
Industry Pharmaceutical Preparations | 603 out of 890 | 32nd |
Source: SEC filing on April 28, 2015.
Kassberg's colleagues
We found two more compensation records of executives who worked with Thomas Kassberg at Ultragenyx Pharmaceutical in 2013.